LISATA THERAPEUTICS, INC. Logo

LISATA THERAPEUTICS, INC.

Develops therapies to enhance anti-cancer drug delivery to solid tumors.

LSTA | US

Overview

Corporate Details

ISIN(s):
US1280583022 (+1 more)
LEI:
Country:
United States of America
Address:
110 ALLEN ROAD, 7920 BASKING RIDGE

Description

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-10-02 19:21
FORM 4
English 7.2 KB
2024-10-02 19:19
FORM 4
English 7.2 KB
2024-10-02 19:16
FORM 4
English 7.2 KB
2024-08-21 18:33
424B5
English 251.2 KB
2024-08-12 18:21
10-Q
English 1.9 MB
2024-08-12 18:08
8-K
English 11.2 MB
2024-07-15 18:09
S-8
English 37.7 KB
2024-06-27 18:53
8-K
English 70.4 KB
2024-05-10 02:15 English 5.3 KB
2024-05-09 18:13
10-Q
English 2.1 MB
2024-05-09 18:08
8-K
English 11.0 MB
2024-05-07 18:02 English 166.9 KB
2024-05-06 18:36 English 58.3 KB
2024-05-01 18:02
S-3
English 113.1 KB
2024-04-29 18:53
DEFA14A
English 1.4 MB

Automate Your Workflow. Get a real-time feed of all LISATA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LISATA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LISATA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.